|
|
Volumn 16, Issue 4, 2001, Pages 276-284
|
|
The Twenty-third Annual San Antonio Breast Cancer Symposium
|
|
Author keywords
Breast cancer; Breast cancer symposia; San Antonio 2000
|
|
Indexed keywords
ANASTROZOLE;
ANTHRACYCLINE;
CAPECITABINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIRUBICIN;
ESTROGEN RECEPTOR;
ESTROGEN SULFOTRANSFERASE;
FLUOROURACIL;
FULVESTRANT;
GAMMA INTERFERON;
GOSERELIN;
LETROZOLE;
METHOTREXATE;
PAMIDRONIC ACID;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
TRASTUZUMAB;
ZOLEDRONIC ACID;
ADVANCED CANCER;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER GROWTH;
CANCER HORMONE THERAPY;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG TOLERABILITY;
ENDOSCOPY;
HUMAN;
POSTMENOPAUSE;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
DEOXYCYTIDINE;
ESTRADIOL;
ESTROGEN ANTAGONISTS;
FEMALE;
HUMANS;
MALE;
MASTECTOMY;
NITRILES;
PROGNOSIS;
SURVIVAL ANALYSIS;
TAMOXIFEN;
TREATMENT OUTCOME;
TRIAZOLES;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0035100774
PISSN: 03007995
EISSN: None
Source Type: Journal
DOI: 10.1185/030079901750120213 Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (1)
|
